Keeping current with the retina literature is, for most, an ongoing, futile effort. New journals are constantly being introduced, and existing journals keep getting thicker and thicker. Researching a topic on PubMed doesn’t allow you to spot key references or quickly digest what’s new globally on a topic of interest. And remembering what you’ve read a few weeks later (or even after you’ve turned the page to the next article) is a struggle.
To address these concerns, we pull key clinical references from 24 major ophthalmic and retinal journals each month (click here for the journal list). Although we can’t provide the journal article PDF due to copyright issues, we provide a single-line citation with a brief summary of the article’s main points. Our goal is to capture all major clinically relevant references.
Please contact us if we’re missing any key references or if any reference is mis-summarized or cited.
That’s easy! Just subscribe to the Retina World Congress’s monthly email blast here.
At the top of most Image Library folders is a ___References Word document containing the annotated bibliography for that topic. Every month, we file key articles into the appropriate Retina Rocks folder(s) and update this file. Key articles are located at the top of the list. This allows for a rapid snapshot and review of the literature while also looking through our multimedia images. Some seemingly unrelated references are included in each folder to aid in differential diagnosis or to learn about similar findings in other disorders.
Here is the current month's snapshot of key retina journal articles
Acta Ophthalmol. 2026 Sep;104(6):e662-e670. doi: 10.1111/aos.70134.
nAMD Switching to Vabysmo after prior anti-VEGF for at least 1 year extended the recurrence-free interval — FAR WEST Retrospective, 845 eyes.
Can J Ophthalmol. 2026 Aug;61(4):978-981. doi: 10.1016/j.jcjo.2026.02.008.
Eyes with nasal ROP (vs temporal-only disease) at initial presentation are more likely to require treatment — Retrospective, 542 eyes.
Clin Exp Ophthalmol. 2026 Aug;54(6):796-811. doi: 10.1111/ceo.70128.
AMD hyperreflective foci are likely pigment-containing immune cells or possibly migrating RPE — Review.
Can J Ophthalmol. 2026 Aug;61(4):955-966. doi: 10.1016/j.jcjo.2026.01.020.
Uveal MM: New volume-based classification provides better prognostic discrimination than AJCC system — Retrospective, 5410 consecutive patients.
Retina. 2026 Aug 1;46(8):1345-1362. doi: 10.1097/IAE.0000000000004871.
PPV for large high myopic macular holes: Closure rates lower than non-high myopic eyes but get closure with meaningful VA gains — Retrospective, global, 499 eyes.
Ophthalmol Retina. 2026 Aug;10(8):844-851. doi: 10.1016/j.oret.2026.03.019.
Paclitaxel cumulative incidence for macular edema and cystic maculopathy in 1.4%. More common with older age, female sex, dyslipidemia, liver disease, and greater cumulative dose — Retrospective, US HIRA database.
Indian J Ophthalmol. 2026 Aug 1;74(8):1115-1121. doi: 10.4103/IJO.IJO_1634_26.
Optic neuritis diagnosis and management, Indian Neuro-Ophthalmology Society consensus statement.
J Vitreoretin Dis. 2026 Mar 11:24741264261427832. doi: 10.1177/24741264261427832
No optic pit retinoschisis can have glaucoma at baseline, but more commonly develops thereafter. Consider glaucoma screening at baseline for NOPIR patients — Retrospective, 13 eyes.
Retina. 2026 Aug 1;46(8):1388-1395. doi: 10.1097/IAE.0000000000004861.
Management of PDR within the first year of Dx from 2005 to 2024: Shifted from PRP monotherapy toward anti-VEGF (including combination and monotherapy) — Retrospective, TriNetX database.
Ophthalmol Retina. 2026 Aug;10(8):820-832. doi: 10.1016/j.oret.2026.04.020.
EMAP High-resolution OCT of presumed basal laminar deposits and RPE abnormalities. Highly prevalent with distinct phenotypes — Retrospective, 25 patients.
J Vitreoretin Dis. 2026 Mar 2:24741264261423313. doi: 10.1177/24741264261423313.
Bilateral MacTel2 has high coexisting diabetes and obesity — Retrospective, TriNetX database.
Ophthalmol Retina. 2026 Aug;10(8):801-812. doi: 10.1016/j.oret.2026.04.005.
Pediatric macular holes: PPV high visual and anatomic success. Many also spontaneously resolve without surgery. Recommend individualized approach — Retrospective, IRIS registry.
Retina. 2026 Aug 1;46(8):1380-1387. doi: 10.1097/IAE.0000000000004857.
Optos UWF imaging: Enhancing standard RG images with filtering techniques improves sensitivity for detecting PDR and NV while maintaining specificity — Retrospective, 30 eyes.
Ophthalmic Surg Lasers Imaging Retina. 2026 Aug;57(8):492-498. doi: 10.3928/23258160-20260521-03.
Post-Syfovre IOI + vasculitis 24 eyes (22 patients, 306,000 injections between 3-1-23 and 8-31-24). Median 10 days post-injection. 88% after 1st injection — Retrospective, Apellis, All reported cases.
JAMA Ophthalmol. 2026 Aug 1;144(8):705-711. doi: 10.1001/jamaophthalmol.2026.2245.
In ophthalmology clinics, uncontrolled or previously unrecognized HTN highly prevalent (even for those engaged in routine medical FU) — Prospective, 172 patients.
Indian J Ophthalmol. 2026 Aug 1;74(8):1169-1173. doi: 10.4103/IJO.IJO_2643_25.
Idiopathic intracranial HTN: Anemia and obesity are distinct triggers, BUT both groups have comparable structural and functional profiles — Prospective, 92 patients.
Eye (Lond). 2026 Aug;40(12):1929-1934. doi: 10.1038/s41433-026-04612-z.
Post-Vabysmo nAMD IOI in 0.13% of injections (14 eyes, 10805 injections). Mostly anterior and steroid-responsive with good final VA.
Acta Ophthalmol. 2026 Aug;104(5):e565-e577. doi: 10.1111/aos.70106.
ICSC Eplerenone vs PDT: Confirms PDT efficacy; 90% of initial eplerenone eyes failed at 3 months, but then 88% responded to PDT — SPECTRA RCT, 107 patients.
Eye (Lond). 2026 Aug;40(12):1914-1919. doi: 10.1038/s41433-026-04608-9.
UWF photos have limited sensitivity for detecting retinal breaks in preop RRD. Complements but doesn’t replace scleral depressed exam.
Retina. 2026 Aug 1;46(8):1415-1423. doi: 10.1097/IAE.0000000000004837.
Centenarians with nAMD can maintain VA with long-term anti-VEGF therapy —Retrospective, 28 eyes (14 patients).
Ophthalmol Retina. 2026 Aug;10(8):792-800. doi: 10.1016/j.oret.2026.04.004.
Fellow eye develops macular hole in 12% at 5 years. Main risks are VMT and no PVD — Retrospective, 576 patients.
Ophthalmology. 2026 Aug;133(8):1029-1035. doi: 10.1016/j.ophtha.2026.04.008.
NAION and GLP1 agonists: small but possible increased risk, which remains low. Consensus statement by the North American Neuro-Ophthalmology Society and American Academy of Ophthalmology.
Receive Retina Rocks content in the RWC monthly newsletter!
Retina Rocks is the image bank of the Retina World Congress.